Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide Inhalation Suspension Long-Term Extension in Japanese Children with Asthma
NCT00232648Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2004
- Primary completion
- Nov 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of budesonide in asthma, sponsored by AstraZeneca. Primary endpoint: Safety profile of long-term use. Started Jan 2004; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00232648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232648.